drugset / Trial / NCT00567216
Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding
Phase 4
Unknown
120 enrolled
Taipei Veterans General Hospital, Taiwan
National Science and Technology Council, Taiwan · collab
RandomizedParallel-groupSingle-blindPrevention
Summary
Gastric variceal bleeding has a very high rebleeding rate even after endoscopic variceal injection of cyanoacrylate (GVO) which is considered the first choice of endoscopic treatment. Beta-blocker (BB) is effective to lower portal pressure. We hypothesized combination of GVO and BB can further decrease the rebleeding rate.
Timeline
- Start
- 2007-04
- Primary completion
- —
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nadolol | Unknown | 20 mg | — |